Cite
HARVARD Citation
van Mens, L. et al. (2018). Brief Report: Interleukin‐17 Blockade With Secukinumab in Peripheral Spondyloarthritis Impacts Synovial Immunopathology Without Compromising Systemic Immune Responses. Arthritis & rheumatology. 70 (12), pp. 1994-2002. [Online].